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ABSTRACT 
 Objective: The purpose of this randomized parallel two-arm trial was to examine 
the effect that an intervention of combining daily almond consumption (2.5 ounces) with 
a walking program would have on heart rate recovery and resting heart rate when 
compared to the control group that consumed a placebo (cookie butter) in men and 
postmenopausal women, aged 20-69, in Phoenix, Arizona.  
 Design: 12 men and women from Phoenix, Arizona completed an 8-week walking 
study (step goal: 10,000 steps per day). Subjects were healthy yet sedentary, non-
smokers, free from gluten or nut allergies, who had controlled blood pressure. At week 5, 
participants were randomized into one of two groups: ALM (2.5 oz of almonds daily for 
last 3 weeks of trial) or CON (4 tbsp of cookie butter daily for last 3 weeks of trial). Body 
weight, BMI, and percent body fat were measured using a stadiometer and Tanita at the 
screening visit. Resting heart rate, heart rate recovery, and anthropometric measurements 
were taken at weeks 0, 5, and 8.  
 Results: 8 weeks of walking 10,000 steps per day, with or without 3 weeks of 
almond consumption did not significantly improve heart rate recovery (p=0.818) or 
resting heart rate (0.968).  
 Conclusions: Almond consumption in combination with a walking intervention 
does not significantly improve heart rate recovery or resting heart rate.  
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Chapter 1 
INTRODUCTION 
Overview  
Cardiovascular disease (CVD) remains the number one cause of death worldwide 
for both men and women. In the United States alone, 610,000 people die of heart disease 
every year. CVD is one of the many conditions linked to obesity, which has become a 
large concern over recent decades
25
. Poor diet and physical inactivity are two risk factors 
for heart disease. There is a dire need for a health intervention strategy that is simple to 
follow. 
Walking is one of the easiest forms of exercises for Americans to implement in 
their daily lifestyle. Going for a brisk walk for 30 minutes per day can qualify a person to 
meet the physical activity guidelines
48
. Heart rate recovery (HRR) is a measure of 
physical fitness that is used to predict risk for CVD, as well as mortality. HRR has been 
shown to be directly related to cardiovascular health and physical fitness. Almonds and 
physical activity are both linked to reduced risk for CVD. Almond consumption has been 
related to improved athletic performance and endurance
106
,
 
weight loss and improved 
lipid profiles
1, 37
. Due to the evidence that HRR and resting heart rate (RHR) are 
predictive of CVD and metabolic syndrome
95 
, it would be beneficial to study 
whether the addition of almonds to the diet while following a walking intervention would 
improve HRR and RHR. 
There is no research that specifically studies the consumption of almonds during 
exercise interventions. Given that these factors independently reduce the risk for CVD, it 
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is important to see if the combination of the two interventions results in a greater 
improvement in HRR. It was expected that the walking protocol would improve fitness 
measures in both groups. Significant changes were expected to be related directly to 
almond intake versus the placebo intake. If this combination of interventions was shown 
to be effective, it could be used to create a simple prevention strategy against the largest 
cause of death around the globe.  
Purpose of Study 
 The objective of this study was to examine the effect that an intervention of 
combining daily almond consumption (2.5 ounces) with a walking program would have 
on heart rate recovery when compared to the control group that consumed an iso-caloric 
placebo (cookie butter) while on the same walking program. For each group, the almonds 
or placebo butter were consumed as a daily snack to fuel their walking program. No 
studies have tested whether almond consumption has an effect on HRR.  
Research Aim & Hypothesis 
It was hypothesized that daily almond consumption would result in improved 
HRR measures in comparison to the control treatment. There is also no evidence in the 
literature that shows a relationship between almonds and resting heart rate. The 
secondary hypothesis was that there would be no relationship between almond 
consumption and resting heart rate in comparison to the control treatment.   
Definition of Terms 
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Heart rate recovery: the decrease in heart rate immediately following exercise. Measured 
as the drop in heart rate (beats per minute) from the time exercise stops to one minute 
post-exercise. The higher the heart rate recovery, the better, as this means the heart rate 
returns to normal in a shorter period of time.  
Resting heart rate: heart rate, measured in beats per minute, when a person is at complete 
rest.  
Delimitations 
Participants were sedentary men and postmenopausal women who sit for at least 8 
hours a day. The results do not apply to children, premenopausal women, or active adults. 
Limitations 
This study included a self-feeding and self-monitoring protocol. The participants 
consumed the assigned snack on their own, and investigators did not directly observe the 
consumption of the snack or the walking. Compliance calendars were used to document 
the ingestion of the test foods, though not all participants followed instructions to mark 
off their calendar when they consumed their daily snack. The use of the step test instead 
of VO2 max was also a limitation. The time period of 8 weeks may have been too short to 
allow participants to experience significant changes in heart rate recovery and resting 
heart rate. The sample size was too small to see any significant differences. A larger 
study using at least 50 subjects may be needed to attain adequate power to detect 
significant results.  
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Chapter 2 
LITERATURE REVIEW 
Nut Benefits. Nuts are an energy-dense snack that are rich in monounsaturated and 
polyunsaturated fats and other beneficial nutrients. Despite the high energy content, 
epidemiological studies indicate that regular consumption of nuts does not contribute to 
obesity or the onset of diabetes. On the contrary, nuts have actually been shown to aid in 
weight loss. Nuts act as an appetite suppressant and regulate fat absorption. They have a 
wide array of cardiovascular and metabolic benefits. With nuts being an easy snack to 
prepare, using nuts as a part of dietary intervention may support weight management and 
improve metabolic health
20
. 
Almond Nutrients. Among the many types of nuts, almonds are one of the most 
beneficial. They are rich in monounsaturated fats, fiber, vitamin E, magnesium, copper, 
phosphorus and phytonutrients. They are also rich in arginine and quercetin. Fiber 
consumption, in combination with the consumption of beneficial fats, results in a 
cholesterol-reducing effect. Other benefits specific to almonds are glucose homeostasis, 
reduction in inflammation and oxidative stress, and management of body weight. 
Evidence shows that almonds can be used to treat and manage high cholesterol, metabolic 
syndrome, and type 2 diabetes
62
. A study that replaced saturated fatty acids in the diet 
with almonds and then walnuts. After a 3-week period of daily almond ingestion (84 g/d), 
participants had a 7% reduction in total cholesterol and a 10% reduction in LDL 
cholesterol. The researchers cited the monounsaturated fats as the cholesterol-lowering 
mechanism
2
. The data from a study in which subjects ate 5 different meals with washout 
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periods in between indicated that almonds decrease the glycemic and insulinemic 
responses to bread. The researches attributed this decrease to the antioxidant activity of 
almonds, which preserved protein thiols. Low protein thiols are a marker of oxidative 
stress. The results of this study indicate that lowering of postprandial glycemic and 
insulinemic responses following nut consumption may also contribute to the lower risk of 
CVD associated with almond consumption
58
. Frequent nut and seed consumption is 
linked with low levels of inflammatory markers, including C-reactive protein, IL-6 and 
fibrinogen. In a randomized control crossover feeding study, participants on a high-
almond diet had 7.8% decrease in E-selectin than the control group, and 6.3% decrease in 
E-selectin than the low-almond group. E-selectin is an adhesion molecule, which when 
present indicates endothelial dysfunction.  A decrease in E-selectin could lower 
inflammatory response, which could in turn decrease the risk for CVD. These 
investigators also contribute these results to the monounsaturated fatty acids in 
almonds
84
. Vitamin E, another component of almonds, stops lipid peroxidation. Lipid 
peroxidation reduces the capacity of cell membranes to maintain an equilibrated gradient 
of concentration, and increases membrane permeability and inflammation
36
.  
Modality of Almonds in Protection against Heart Disease. Though it is well-
known that almonds are protective against heart disease, researchers are still working to 
understand mechanisms. A study of almond supplementation in rats found that the 
activation of HMG-CoA reductase in a tyloxapol model enhanced de novo cholesterol 
synthesis, which resulted in hypercholesterolemia. The tyloxapol was injected purposely 
to induce hyperlipidemia. One working theory is that the vitamin E and phytosterols in 
almonds are inhibitory against HMG-CoA reductase. Almond-induced 
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hypertriglyceridemia may be controlled through actions on the enzymes lipoprotein lipase 
and lecithin-cholesterol acyltransferase, which in turn would result in the promotion of 
triglyceride clearance. These investigators also propose that almonds prevent endothelial 
dysfunction by inhibition of smooth muscle cell proliferation, prevention of vascular 
calcification, regulation of LDL-C oxidation in plaques by inhibiting the increase in 
serum GGT,  the minimization of vascular fat accumulation by improving liver function 
and promoting reverse cholesterol transport, improving acetylcholine-induced aortic 
relaxation, restricting eNOS inhibition, and increasing serum NO. Overall, the findings of 
this study were that almonds inhibit de novo cholesterol synthesis, prevent hepatic 
damage, and restore vascular function. These are all ways that almond consumption may 
be playing a role in preventing cardiovascular disease and metabolic syndrome. Future 
studies may be able to link almonds to enhanced fitness measures based on factors such 
as serum NO
57
. A randomized parallel-group trial examined the effect of sixteen weeks of 
almond supplementation (2 oz per day) on insulin sensitivity and other cardiovascular 
risk factors in an adult population with prediabetes. The almond intervention was 
associated with lower fasting insulin levels in comparison to the control group. Fasting 
insulin is a marker of insulin resistance. The researchers propose that the high oleic acid 
content in the almonds may improve beta-cell efficiency, which results in improved 
insulin efficiency. This is beneficial for the prevention of CVD, as elevated fasting 
insulin and postprandial insulin levels along with impaired carbohydrate tolerance are 
associated with a higher risk of CVD
103
. A randomized crossover trial consisted of three 
1-month diet phases, each separated by a 2-week washout period. The three phases were 
a control (muffin), a full dose of almonds (~73 g/d), and a half dose of almonds (~37 g/d) 
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with a muffin. The full dose phase resulted in a 9.4% reduction in LDL from baseline. 
The half dose phase resulted in a 4.4% reduction in LDL from baseline. Based on this 
data, the researchers surmise that a dose response of 7 g of almonds per day results in a 
1% reduction of LDL cholesterol, which equates to a 2% reduction in risk for coronary 
heart disease (CHD). The full dose of almonds was also associated with a decreased 
calculated risk of CHD based on total HDL cholesterol and blood pressure data
59
.  
Almonds and Vascular Function. Vascular function is another health component 
that can be improved by the consumption of almonds. A study at Tufts University studied 
the effect of almond consumption on vascular function in patients with coronary artery 
disease. This was a randomized control trial that issued participants either a diet that 
included almonds, or a control diet that did not include almonds. While the study 
examined outcomes such as flow-mediated dilation, blood pressure, oxidative stress, and 
blood lipids, fitness outcomes were not measured. Exercise was not a variable in this 
trial. In this particular study, almonds did not significantly impact vascular function. The 
addition of exercise in such a trial may result in a different impact on vascular function
18
. 
Nuts contain unsaturated fats, which have favorable effects on blood lipids, a marker that 
is used to predict cardiovascular risk. Nuts are also rich in arginine, which is the 
precursor for nitric oxide. Nitric oxide is a potent vasodilator and can inhibit platelet 
adhesion and aggregation. The anti-atherogenic effect of nuts may be related to the 
arginine-NO pathway
53
. The consumption of nuts is inversely associated with levels of 
inflammatory markers, CRP, IL-6 and fibrinogen. This is important for vascular function, 
as inflammation contributes to all phases of atherosclerotic disease. This includes initial 
recruitment of circulating leukocytes to inducing endothelial dysfunction and plaque 
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rupture. Reducing the levels of inflammation by consuming nuts may prevent 
atherosclerotic disease
66
. A 4-week almond supplementation design was used in a study 
investigating whether almond supplementation can improve oxidative stress and 
cardiovascular risk factors. Participants consumed a daily snack of 50 g of almonds. 
Plasma triacylglycerol and HDL and LDL cholesterol remained unchanged after the 4 
weeks. Plasma α-tocopherol corrected for LDL concentration increased significantly 
from 6.6±0.4 to 6.8±0.44 mmol α-tocopherol/mol LDL after the 50 g/d almond 
supplementation. Despite this improvement, there was no correlation between changes in 
LDL and α-tocopherol levels and measures of vascular function19. 
Almonds and Weight Loss. The consumption of nuts has been linked to weight 
loss and weight maintenance in numerous studies. One randomized control trial studied 
the effects of a balanced diet that included almonds on weight and cardiovascular risk 
factors in overweight adult women. Women who consumed 50 g of almonds per day for 
three months had significantly greater weight loss than the women who followed a nut-
free diet. The almond group also showed significant decreases in BMI, waist 
circumference, and waist to hip ratio. This group also showed improvements in 
triglyceride and total cholesterol levels
1
. Data from the 1994-1996 Continuing Survey of 
Food Intakes by Individuals by the USDA show that young persons and adults that 
consumed nuts had lower BMI compared to those who did not. The nut consumers had 
higher energy intakes, yet lower BMI. Multiple studies observed that subjects assigned a 
nut diet either maintained or lost weight, rather than gaining weight
52, 87
. In a randomized 
cross-over study, participants received a daily almond supplement (320 calories) for six 
months with no additional dietary advice. The daily almond consumption did not lead to 
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significant weight gain
38
. A randomized, parallel-arm study in which test subjects 
consumed almonds as a snack for 4 weeks found that despite an additional 250 kcal/day 
in the subjects consuming almonds, daily energy intake was not significantly higher than 
at baseline, and weight did not change significantly between study groups
97
. Subjects 
typically compensate by reducing food intake from other sources. In a study by Hollis, et 
al., inefficiency in the absorption of almonds was documented
47
. In another study in 
which participants either consumed a low calorie diet including almonds or a low calorie 
diet including self-selected complex carbohydrates, the almond group experienced and 
sustained a greater weight reduction over a 24 week period than the complex 
carbohydrate group
104
. In both the Adventist Health Study and Nurses’ Health Study, 
those who consumed more nuts tended to weigh less
53
. The nutrient profile of almonds 
may promote a feeling of satiety, which is beneficial to those attempting weight loss. The 
protein, fiber, and fat content of almonds allows individuals to feel full for longer periods 
of time.  
Almonds and Exercise Performance. While there is a deficiency in the literature 
regarding almond consumption during a walking program, there are studies that have 
shown a relationship between almond consumption and improved exercise endurance and 
performance. One study examined the effect of almonds on elements of endurance 
exercise performance in trained athletes. Participants either consumed 75 g of almonds 
per day (ALM) or an isocaloric cookie (COK). Investigators measured carbohydrate and 
fat oxidation, energy expenditure, oxygen use, glucose levels, and biochemical markers. 
The consumption of 75 g of almonds per day resulted in increased cycling distance 
compared to the control group. It was also noted that ALM had lower oxygen 
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consumption than COK during the 20-minute time trial. ALM also had lower blood free 
fatty acids and higher blood glucose post-exercise when compared to baseline. This 
indicates that almonds may assist athletes by mobilizing reserved carbohydrates instead 
of breaking down fat as a source of energy during training and intense exercise107. 
Untrained subjects in an exercise fatigue study were able to delay the sensation of 
exhaustion with almonds. The data from this study suggest that the ingestion of the fat 
from the almonds delayed the exhaustion to a greater extent than carbohydrate ingestion
3
. 
In a study where mice were given a placebo or quercetin for 7 days, the quercetin group 
had increased exercise capacity (p < 0.05). The mice with a 12.5 mg/kg dose increased 
treadmill run time by 36% and those with at 25 mg/kg dose increased treadmill run time 
by 37%. Mice fed 25 mg/kg of quercetin for 7 days increased their voluntary time (p < 
0.05) and running distance (p < 0.05) on an exercise wheel in comparison to a placebo 
group
23
. There are few studies specifically regarding almonds and exercise performance, 
however the discussion in this review about the individual nutrients that are in almonds 
will shed some more light on the potential benefits of almond consumption on exercise 
performance. 
Mastication of Almonds. To determine the serving size for the isocaloric placebo 
snack, it is important to review the available literature on the energy value of almonds. 
Studies have shown that the energy value from digested almonds is less than the value 
shown on labels or as calculated by the Atwater method. Mainly due to mastication, the 
digestibility of fat from almonds and other nuts is lower than fat in other foods that are 
digested in a more complete manner. Due to incomplete breakdown of almond particles 
during mastication, cell walls that encapsulate the lipids remain unbroken, resulting in a 
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lower metabolizable energy content. The actual energy content derived from almonds 
after digestion was found to be 129 kcal per 28 g in comparison to the amount determined 
by the Atwater factors, which was 168 to 170 kcal per 28 g 
15, 44, 79
. There is evidence to 
show that consuming almonds as a snack may be more beneficial than consuming them 
with a meal. Consuming almonds as a snack is an easy method to aid weight control, as 
they tend to result in a feeling of satiety and a lower level of hunger and desire to eat at 
the meal that follows the snack. Almonds also lower glucose responses postprandially. 
This effect was more prominent in the snack group when compared to those consuming 
almonds with a meal
97
.  
Weight loss and HRR. When the effects of a low calorie diet on post-exercise 
heart rate in obese men was studied, it was found that with weight loss, significant 
improvements in HRR were found at 90 seconds and 120 seconds post-exercise. The 
warm up consisted of a 5-minute stretching session, then two minutes on the bicycle 
ergometer at 0W. The workout started at 15 W, and then every minute 15 W was added 
gradually until the subject’s capacity was reached. Blood glucose, triglycerides, and 
lipids also decreased significantly with weight loss. The author proposed that the exercise 
itself had a bigger impact on these measures than the fact that the participants lost weight. 
Improvements in HRR after exercise reflect improvements in the function of the vagus 
nerves and VO2 max, which will in turn decrease the risk for cardiovascular disease
64
.  
Physical Activity Recommendations. The aerobic activity recommendations by the 
American College of Sports Medicine and Centers for Disease Control and Prevention 
are that adults between the ages of 18 and 65 should perform moderate-intensity physical 
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activity for a minimum of 30 minutes five days a week, or vigorous aerobic exercise for a 
minimum of 20 minutes three days a week. Walking at a brisk pace for 30 minutes five 
times each week qualifies most Americans to meet these guidelines
48
. In terms of walking 
in relation to the physical activity guidelines, walking at an average pace for 30 minutes 
would equate to 2 miles or roughly 4,000 steps (The Walking Site). Only 22% of a 
sample of British men performed the minimum recommended amount of exercise. Not 
only did a small amount of participants exercise, but the amount of sedentary individuals 
increased with age. The number of subjects that exercised at least three times a week did 
not vary between age groups, which suggests that developing this schedule as a habit in 
or before early adulthood will raise the likelihood of continuing to do so into later 
adulthood. Increasing age results in the deterioration of health parameters, but the 
addition of exercise into a person’s lifestyle can result in beneficial health changes and 
improve these parameters
9
. Meta-analyses of walking intervention studies have shown 
that walking alone can improve a number of cardiovascular risk factors. Interestingly, the 
majority of walking interventions have female participants. In a systematic review by 
Hanson et. al, 43% of the studies were for women only. 76% of the participants across 42 
studies were female in this review
47
. This is a delimitation that can be addressed by 
recruiting men for future walking interventions. In the meta-analysis by Murphy, et al., 
the mean length of program was 34.9 weeks, with the mean volume of walking 188.8 
minutes per week. Of 1,128 participants, 87.8% complied with the walking 
intervention
75
. Overall, studies in both meta-analyses showed an increase in VO2 max. 
Statistically significant changes were found in resting heart rate, total cholesterol, 6-
minute walk time, systolic blood pressure, and diastolic blood pressure. Participants also 
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reported feeling less depressed and had a better quality of life. Decreases in BMI and 
body fat were apparent in both reviews
47, 75
. One particular study had participants in 
different groups performing different “bouts” of walking. The single-bout group did a 20 
minute walk in one period. The accumulated-bout group did two separate 10-minute 
walking bouts in a day. Interestingly, the single-bout group had a greater reduction in 
heart rate than the accumulated-bout group
76
.  
Sedentary Activity Recommendations. While chronic disease risk is often defined 
by how much time a person spends doing physical activity, recent literature suggests that 
time spent sitting can also be indicative of risk. While guidelines about being more active 
are specific and quantitative, guidelines regarding sitting time tend to be very broad. It is 
suggested that people minimize their sitting time and to take breaks during long periods 
of sitting, but these guidelines are not specific
60
. While sedentary is often thought of as 
“not exercising,” people who exercise may also engage in a great deal of sedentary 
activity throughout the day. Ekblom-Bak suggests that sedentary time should be defined 
as “the muscular inactivity rather than the absence of exercise”32. Guidelines were 
released in the British Journal of Sports Medicine that say desk-based workers should 
aim for at least 2 hours of standing time, and work their way up to 4 hours
13
. Participants 
from the 2003-2004 National Health and Nutrition Examination Survey (NHANES) in 
the United States who wore an activity monitor for up to 7 days spent 57.7%, or 7.7 hours 
of their day participating in sedentary behaviors
73
. The results of a study in New Wales, 
Australia suggested that men who had at least 8 hours per day of sedentary activity had a 
higher incidence of all-cause mortality in comparison to men who had less than 3 hours 
per day of sedentary activity
82
. Another study in Australia found that higher sedentary 
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time was adversely associated with waist circumference, plasma glucose, and 
triglycerides. However, if this sedentary time was paired with light-intensity activity, 
there were beneficial results in waist circumference and plasma glucose. Breaks in 
sedentary time were also associated beneficially with waist circumference, BMI, 
triglycerides, and 2-hour plasma glucose
50
. A larger study found that the successful 
maintenance of weight after a period of weight loss was associated with avoidance of 
watching television, which is considered the most common sedentary behavior
46
. If an 
individual is engaging in the recommended 30 minutes of activity per day, 5 days a week, 
but also sits for at least 8 hours per day, their step count may not add up to over 5,000 
steps per day. For the average American who walks 2,000—3,000 steps per day, it could 
take a 4 mile walk to reach the 10,000 step goal.  
Exercise Interventions and Physical Fitness. A study done between Arizona State 
University and Karolinska Institute found that the more steps participants took in a 
walking intervention, the greater the decline in systolic blood pressure and a greater 
linear decline in diastolic blood pressure, which slowed over time. Number of steps was 
also significantly related to changes in VO2max over time.  An important observation in 
this study was that participants were motivated in the beginning of the study, but over the 
course of the six months, the number of steps taken significantly decreased. The mean 
steps taken early in the study were 12,256 steps per day. This number decreased to 8,586 
steps per day by the end of the six month period. This observation can be used to 
encourage investigators to check in with participants more often to increase compliance 
throughout interventions
94
. Another study followed women who were assigned to one of 
four treatment groups: aerobic walkers, brisk walkers, strollers, and sedentary controls. A 
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linear, dose-response gradient across all walking groups was observed for both VO2 max 
and heart rate
29
. Throughout the literature on walk studies, many of the study protocols 
involved using rate of perceived exertion throughout the exercise program
14, 64, 76, 95, 107
. 
This may be a useful tool to use to encourage participants to maintain a brisk pace 
throughout the 6-week walking intervention.  
In a trial involving premenopausal obese women, the intervention group 
performed 4 or more hours of exercise per week. Significant improvements were shown 
in heart rate recovery at 1 minute post-exercise. At two minutes post-exercise, both the 
control group and intervention group had improved HRR. The intervention group also 
achieved modest weight loss, but the weight loss was not associated with improved 
HRR
14
. These findings are important when considering the management of obesity. With 
or without weight loss, implementing an exercise program can minimize the risk for 
cardiovascular disease.  
A randomized exercise intervention study by Prakhinkit determined the effects of 
Buddhism-based walking meditation (BWM) and the traditional walking exercise (TWE) 
on depression, functional fitness, and vascular reactivity. Body composition was 
measured using a Tanita Body Composition Monitor, and heart rate was measured using 
a Polar heart rate monitor. A 6-minute walk test was used to assess cardiovascular 
endurance. Both TWE and BWM programs were performed 20 minutes each three times 
per week. In the second phase, the time increased to 30 minutes. Phase 1 was performed 
at a mild intensity and phase 2 was performed at a moderate intensity. Buddhist walking 
exercises involve swinging of the arms while voicing “Budd” and “Dha” with rhythmic 
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arm swings. They were also instructed to practice mindfulness while walking. In phase 2, 
the participants increased their workload by holding water bottles in each hand while 
swinging the arms. At the end of this study, BMI and blood pressure decreased in both 
the TWE and BWM groups. In the BWM group, depression scores significantly 
decreased. Plasma cortisol concentrations in the BWM group also decreased. The mind 
and body connection that is incorporated into the Buddhist training method is thought to 
be effective in reducing depression and cardiovascular disease risk factors. Both exercise 
programs also resulted in an increase in plasma NO level. While Buddhist walking 
methods are not typically used in interventions, it is interesting to see that greater risk 
reduction resulted from using this method of exercise
83
.  
A study investigating the beneficial effects of exercise training in elderly people 
with coronary artery disease (CAD) implemented an intervention in which the exercise 
group completed a total of 36 exercise sessions over a period of 12 weeks, This included 
cardiopulmonary exercise training using a cycle ergometer, strengthening exercise 
training using free weights and weight machines, and balance training. Balance training 
consisted of exercises that involve standing, reaching, stepping, and single-limb 
exercises, among others. In the exercise group, HRR improved from a drop in heart rate 
in the first minute post-workout of 13.90/minute to 16.62/minute after training, which is a 
statistically significant improvement
18
.  
VO2 Max and YMCA Step Test. The gold standard for measuring peak oxygen 
uptake is VO2 max done using a treadmill. However, there are other methods to 
determine cardiorespiratory fitness that may be used in situations where using VO2 max 
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is not possible or plausible. The YMCA 3-minute step test is a validated measure of 
cardiorespiratory fitness. It is only valid in subjects that properly perform the step test in 
its entirety, and do not finish early. If a participant terminates the test early, the test is not 
valid. This test entails having a subject step up and down on a 12” step for 3 minutes to 
the beat of a metronome set to 96 beats per minute. Heart rate recovery is measured one 
minute after the subject completes the 3 minute test
108
. It is suggested that the YMCA 
step test is used in studies where there subjects have a low exercise capacity
7
. Another 
study verified this information, by testing the Queen’s College step test in comparison to 
direct VO2 peak measurement. The Queen’s College step test is similar to the YMCA 
step test. Participants step onto a step of 16.25” for 3 minutes at the rate of 24 cycles per 
minute following a metronome. The pulse is then measure from 5-20 seconds after 
completion of the exercise. The height of the step in the YMCA test is 12”, and the heart 
rate is measured at 60 seconds post-exercise. The QCT can be used to measure VO2 peak 
in place of the direct measurement when direct measurement is not plausible
16
. A 
different study investigated the use of the 15-step climbing exercise test and compared it 
to a 6-minute walk test and VO2 max test. The 15-step test, which is similar to the 
YMCA step test, showed to be a comparable test to the VO2 max and 6-minute walk test. 
The authors felt confident that the 15-step climbing exercise test could be used in place of 
a VO2 max test with patients who were intimidated by the VO2 max, or who were unable 
to complete the latter due to medical conditions
86
.  
In a study done at the Kansas University Medical Center, investigators examined 
the ability of the YMCA submaximal exercise test protocol using a total body recumbent 
stepper (TBRS) to predict VO2 peak. Participants were fitted with a Polar heart rate 
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monitor for use during the test. Participants were instructed to maintain a pace of 100 
steps per minute based on the YMCA protocol that was adapted for TBRS. Heart rate was 
measured throughout the test, and recorded until HR returned to baseline. VO2 max was 
actually measured during a separate maximal exercise test for comparison. The 
researchers found that the YMCA submaximal exercise test using the TBRS can predict 
VO2 max (r = 0.919) in a group of heterogeneous individuals with low to moderate risk 
for cardiovascular disease
8
. 
Heart Rate Recovery. Heart rate recovery refers to how much the heart rate falls 
in the first minute after exercise. The average HRR is a drop of 15-25 beats per minute. 
The quicker the recovery, the healthier the heart. The National Academy of Sports 
Medicine advises persons with a HRR of 12 beats per minute or fewer that they should 
not exercise without consulting a physician first
98
. The inability of the heart rate to 
appropriately decrease after exercise is linked to coronary heart disease and mortality. A 
study following a cohort of participants tested for cardiovascular risk factors found that 
the risk of death increased for every one beat decrease in HRR below 25 at one minute
26
.  
Metabolic syndrome is a set of factors that increase a person’s risk for heart 
disease, diabetes, and stroke. The National Cholesterol Education Program’s Adult 
Treatment Panel III report (ATP III) identified six components of metabolic syndrome 
that relate to CVD. These components are abdominal obesity, atherogenic dyslipidemia, 
raised blood pressure, insulin resistance and/or glucose intolerance, proinflammatory 
state, and prothrombotic state. Abdominal obesity is the form of obesity that is most 
strongly associated with metabolic syndrome. This is measured via waist circumference. 
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Atherogenic dyslipidemia is expressed through raised triglycerides and low levels of 
HDL cholesterol. Hypertension is often listed as a metabolic risk factor as it is often 
associated with obesity and insulin resistance. Insulin resistance often leads to glucose 
intolerance. Those with metabolic syndrome often present with high levels of C-reactive 
protein, which is a clinical marker of inflammation. Similarly, a prothrombotic state is 
characterized by increased plasma plasminogen activator inhibitor (PAI)-1 and 
fibrinogen
44
. A study by Sung, et al. studied the relationship between metabolic 
syndrome and heart rate recovery. HRR is indeed a factor that is associated with 
metabolic syndrome. In a study of almost 1,500 subjects, it was found that men have a 
lower HRR than women, and that smokers have a lower HRR than non-smokers. HRR 
was also found to be inversely correlated with age. It was apparent that those with 
metabolic syndrome had an impaired HRR (10.3±11.6 beats per minute) in comparison to 
those without (13.6±9.7 beats per minute). Those with metabolic syndrome also had 
higher RHR. Investigators noted that with an increasing number of criteria of metabolic 
syndrome present, there was a statistically significant difference in HRR. HRR is an 
indicator of vagal activity, which suggests there is a link between metabolic syndrome 
and impaired vagal activity. Delayed heart rate recovery was independently associated 
with metabolic syndrome after adjusting for resting heart rate, age, gender, and smoking. 
The implications of this study are that improving HRR through exercise can lower the 
chances of developing metabolic syndrome, which later leads to CVD. Also, patients who 
already have CVD can use exercise to improve HRR
95
. Another intervention examined 
the effectiveness on two aerobic exercise programs on the modification of metabolic 
syndrome components and its influence on cardiovascular risk in sedentary women. 
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Resting heart rate improved in the continuous exercise group, but not in the intermittent 
exercise or control group. A decrease was noted in the triglyceride/HDL ratio, implying 
there was an improvement in the peripheral response. This is important because it has 
been established that through the release of glucose, membrane surface transport, and 
intracellular flow of the substrate due to glycolysis, aerobic exercises increases peripheral 
insulin sensitivity. The TG/HDL ratio can be used as a low-cost insulin resistance 
marker
88
.  
In a trial with participants randomized into a placebo or omega-3 fatty acid 
supplementation group for two 4-month periods in a crossover design, resting heart rate 
and heart rate recovery at 1-minute post-exercise improved after omega-3 fatty acid 
supplementation. The improvement in RHR was from 73±13 to 68±13, and in HRR was -
27±1- to -32±12 beats/min. Both of these changes were significant. These results suggest 
that a change of just 5 bpm could results in decreased risk for cardiovascular events
80
. 
Another study examined the change in HRR and PHR after 12 weeks of weight loss in 
participants who did not have CVD but had components of metabolic syndrome. There 
was a significant change in HRR, from -33.1±1.4 to -36.9±1.3 beats/min after weight 
loss
10
. These studies suggest that a reduction in HRR by 3-5 bpm can be meaningful, and 
achieved over a period of 3-4 months.  
An interesting observation is that while men have a lower HRR than women, a 
study that explored HRR in children found that boys had a higher HRR than girls. This is 
expected to be linked to the statistic that more young boys are active than young girls. 
Resting heart rate increased with increasing heart rate recovery in these children. Those 
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in the less fit (lower decrease in heart rate post-exercise) category had higher BMI and 
greater levels of triglycerides, LDL and total cholesterol. As HRR increased, HDL 
decreased. A positive relation was also observed between sedentary activities, such as 
watching TV and playing video games, and decreased fitness
91
.  
In a study that examined the relationship between step count and health outcomes, 
it was observed that those who accumulated ≥5,000 steps per day or more had lower body 
fat percentage, waist circumference, and a higher estimated VO2 when compared with 
those who walked less than 5,000 steps. The study also noted that day-to-day walking 
behavior is often inconsistent. The researchers also reported that those who walked more 
were more frequently classified as “normal weight”81. A study investigating the effects of 
an 8-week, pedometer based physical activity intervention showed that the average step 
count for college employees participating in the study was 8565±3121 steps at baseline. 
At the end of the 8-week intervention, the average step count had increased to 
10,538±3681 steps
22
. While the average step count for college employees based on the 
Croteau study is closer to the 10,000 step goal, a study looking at physical activity in 
adults over the age of 65 reported that the average step count at baseline amongst the 36 
participants was just 2,992 steps per day. Over a 4-week period, the average step count 
increased to 3,670 steps per day. However, that increase was not sustained after a 
washout period in which the participants did not wear the pedometers. This suggests that 
wearing a pedometer may be a successful tool when it comes to increasing activity, but it 
would need to be worn on a regular basis to sustain the change
93
.  
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Atherosclerosis. One cause of cardiovascular disease is atherosclerosis, which is 
prevalent in middle-aged men. Although little research has been done to analyze the 
relationship between almond consumption and atherosclerosis, there was a study that 
examines the effect dried plums have on the progression of atherosclerosis. Plums are in 
the same genus as almonds. The relationship may be one to examine in the future. The 
study on dried plums found that feeding plum powder to mice with atherosclerotic lesions 
reduced the area of the lesions
39
. An analysis of physical activity surveys found that there 
was no relationship between atherosclerosis and self-reported physical activity
42
. A study 
published in the Journal of the American College of Cardiology examined the effects of 
physical activity on early markers of atherosclerosis in pre-pubertal obese children. Some 
of these markers included flow-mediated dilation, BMI, body fat, V02 max. Children 
randomly assigned to an exercise group saw significant changes in blood pressure, BMI, 
abdominal fat, and V02 max at 3 months
35
. The Los Angeles Atherosclerosis Study 
examined the relationship between physical activity and the 3-year progression of carotid 
atherosclerosis. The progression of atherosclerosis was measured by carotid intima-media 
thickness. The thickness was increased nearly threefold in the sedentary group compared 
to the regular physically active group. Regularly physically active was defined as doing 
activities that cause sweating 3.5 times per week. The findings of this study suggest that 
someone increasing their activity from sedentary to moderate, or moderate to regular 
should slow the progression of carotid atherosclerosis
78
.  
Heart Rate Monitors. Measuring heart rate manually is a possible delimitation 
depending on the experience of the investigator performing the test. Using a heart rate 
monitor is a simple, safe solution. Multiple studies in the past have used Polar watches to 
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measure heart rate and calories burned based on anthropometrics. In a study examining 
energy expenditure during gait of patients with mucopolysaccharidosis (MPS), the Polar 
FT7 was used to determine said energy expenditure during a 50 meter walk. The watch 
was used to record initial heart rate, heart rate at the end of the walk, and total time of 
gait. The energy expenditure was provided based on anthropometric measurements and 
heart rate. In comparison to the control group, the MPS group had a 22% higher initial 
heart rate and 13% final heart rate, indicating that MPS patients have a decreased 
cardiopulmonary capacity and increased difficulty performing the walking task
72
.  A 
study evaluating the effect of hydrogymnastics on the serum level of immunoglobin A in 
elderly women also used the Polar FT7 to measure the training intensity of the aerobic 
exercise to keep participants at 50-60% of their maximum heart rate
45
. Studies have been 
done to specifically test the accuracy of other models of the Polar watch. A study 
published in Medicine & Science in Sports Medicine examined the accuracy of the Polar 
S410 HRM for estimating energy expenditure (EE) during exercise when using both 
predicted and measured VO2 max and HR max versus indirect calorimetry. The study 
found that the Polar S410 HRM provides a rough estimate of mean energy expenditure 
for all exercise modes, but did note that the mean EE in females was overestimated by 
12%
20
. A different study published in the Journal of Sports Science and Medicine 
examined the accuracy of the Polar S810i and Sensewear Pro Armband for estimating 
energy expenditure during indoor rowing versus indirect calorimetry. Individual 
estimates of energy expenditure did vary. The results suggest that the Polar HRM may be 
accurate for estimating EE in obese or overweight adults, but that actual VO2 max and 
HR max need to be entered into the watch, rather than using the watch calculations. 
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Additional benefits of using the SWA included ease of use and attachment, and little to 
no discomfort or interference in activity
2
. 
Polyunsaturated Fats. Polyunsaturated fatty acids are one of the components of 
almonds that may be associated with improvements in fitness measures. One study 
investigated the effect of PUFA on inflammation, reversal of muscle wasting, and 
functional status in chronic obstructive pulmonary disease (COPD). The results of this 
study showed that COPD patients had increased functional capacity after 8 weeks of 
PUFA supplementation in comparison to a placebo-controlled group. This was displayed 
through improvements in peak exercise capacity and submaximal endurance time. PUFA 
upregulate peroxisome proliferator activated receptors (PPARs), which have been shown 
to promote the uptake of circulating fatty acids by cells through the upregulation of the 
lipoprotein lipase gene. The receptors also control mitochondrial fatty acid import and β-
oxidation. The increase in exercise capacity in this study may be a result of the PUFA-
induced activation of PPARs.  The dosage of PUFA in this study consisted of 3.4 g of 
active fatty acids, as well as a blend of stearidonic acid, gamma-linoleinic acid, alpha-
linoleinic acid, eicosapentanoic acid, and docosahexanoic acid in a capsule. The placebo 
was also given in capsule form. This was consumed daily for 8 weeks. The increased 
exercise capacity shown in this study indicates that a daily supplementation of PUFA for 
8 weeks is sufficient
11
. Improved heart rate recovery was also seen in two studies that 
involved the consumption of omega-3 PUFA
51, 69
. Further studies need to be done to 
determine whether PUFA consumption can improve resting heart rate and heart rate 
recovery in healthy individuals. It is worth noting that almond consumption may help 
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those who are at risk for CVD or already have elevated resting heart rate when 
considering the past literature on PUFA
57
.  
Arginine. Arginine is another component found in almonds, that is a substrate for 
synthesis of nitric oxide. Arginine, along with quercetin, may help enhance the 
effectiveness of training on exercise performance through the up-regulation of 
mitochondrial biogenesis and oxygen sparing capacity and by facilitating oxygen delivery 
to skeletal muscle. A clinical trial showed that an arginine and antioxidant-containing 
supplement increased the anaerobic threshold in elderly cyclists, potentially indicating 
that L-arginine can improve exercise performance in the elderly population. This clinical 
trial consisted of just three weeks of L-arginine supplementation
18
. The researchers in 
another study suggest that arginine can effect insulin secretion and muscle glycogen 
synthesis. They also suggest that arginine and quercetin may contribute to reserving and 
using more carbohydrate and enhancing more effective oxygen utilization, which further 
results in improvements in exercise performance
107
. A study that aimed to determine the 
effects of oral L-arginine supplementation on physiological functions in soccer players 
did find that the supplementation significantly decreased blood pressure and increased 
VO2 max, blood flow, femoral artery diameter, and urea levels. Other studies have shown 
that intravenous administration of L-arginine resulted in similar improvements. Short-
term oral L-arginine supplementation has been shown to improve endothelial function in 
the femoral artery, reduced arterial blood pressure and increased femoral artery diameter, 
peak systolic velocity, and-diastolic velocity and VO2 max. The researchers in this study 
suggest that L-arginine may have increased VO2 max through an exercise-induced 
increase in cardio output via decreasing the ventricular afterload
62
. A six week trial 
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examining the effect of oral L-arginine supplementation found that L-arginine enhanced 
endurance exercise tolerance. This was demonstrated through a reduction in heart rate 
and circulating lactate
26
. Yet another study determined that a single dose of arginine 
resulted in an increased time to exhaustion during maximal incremental exercise
106
.  
While L-arginine has been shown to improve VO2 max and other exercise-related 
measures, it has not been shown to improve heart rate recovery time in any study to date.  
Quercetin. Quercetin is another component of almonds that has been associated 
with lower risk of cardiovascular disease and diabetes mellitus, and may contribute to 
improved exercise performance. A six-week study showed that a daily 150 mg quercetin 
supplementation significantly reduced systolic blood pressure and plasma oxidized low 
density lipoprotein (LDL) concentrations. The subjects were overweight and had been 
identified as high-risk for CVD based on their phenotype. The researchers suggested that 
quercetin may be protective against CVD
30
. One study examined the effects of seven 
days of quercetin supplementation on maximal aerobic capacity and fatigue in healthy, 
yet untrained individuals. The seven day supplementation did result in a significant 
increase in VO2 max, as well as a significant increase in ride time to fatigue
23
. Another 
trial tested the effects of two weeks of quercetin supplementation in untrained, adult 
males. This supplementation resulted in a significant improvement in a 12-minute 
treadmill time trial performance. The same study demonstrated that 100 mg/day of 
quercetin promoted skeletal muscle mRNA expression of genes involved in 
mitochondrial biogenesis
77
. A meta-analysis in 2011 reported that quercetin has a small 
but significant ergogenic effect on endurance performance
65
. In a study where mice were 
supplemented with quercetin during exercise sessions, they were found to have 78% 
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atherosclerotic plaque reduction in comparison to control mice (no exercise or quercetin) 
and 40% less atherosclerotic plaque formation in comparison to the control group that 
was supplemented with quercetin but did not exercise. This is important because 
atherosclerosis is a major cause of CVD
40
. Another study found quercetin 
supplementation in athletes may improve some performance indices. An 8-week daily 
supplementation of quercetin resulted in increased lean body mass, total body water, 
basal metabolic rate, and total energy expenditure
5
. A trial that supplemented rats with 
quercetin for 5 weeks found that heart rate and blood pressure were reduced in 
spontaneously hypertensive rats
28 
. No such studies regarding quercetin and heart rate 
have been done with human subjects. There are numerous benefits of quercetin 
supplementation in relation to cardiovascular disease and exercise performance. The 
study in rats suggests that heart rate recovery may be improved by dietary quercetin 
intake.  
Vitamin E. Vitamin E is an antioxidant that is found in almonds. Vitamin E 
supplementation has been shown to prevent exercise-induce lipid peroxidation and also 
inhibits enzyme leakage after exercise
89
. Vitamin E deficiency increases susceptibility to 
free radical damage, as shown in exercised rats
34
. Vitamin E prevents atherosclerosis by 
inhibiting the generation of oxidized LDL, reducing the formation and uptake of 
cholesteryl ester, decreasing the proliferation of smooth muscle cells, and by preventing 
inflammation as well as preventing the adhesion of monocytes and macrophages to the 
endothelium
85
. A 16-week exercise and vitamin E supplementation trial found that 16 
weeks of moderate-intensity exercise and 16 weeks of vitamin E supplementation (either 
alone or combined) reduced lipid peroxidation induced by free radicals in older men and 
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women. In both exercise groups, participants had decreases in weight and blood pressure, 
as well as increases in VO2 max. Another study found that 10 daily injections of 100 
mg/kg body weight of Vitamin E in rats resulted in improved functional recovery of heart 
rate
101
. Such studies have not been done in humans. Vitamin E has many benefits in 
relation to fitness measures, and may be beneficial in reducing heart rate recovery time.     
There is evidence that walking and almond consumption independently improve 
cardiovascular health and fitness measures. There is a deficiency in the literature 
regarding a combination of both of these interventions to improve cardiovascular fitness.  
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Chapter 3 
 METHODS  
Participants 
Subject selection 
Subjects were considered eligible for the study if they were sedentary (fail to meet 
Physical Activity Guidelines for Americans and/or spend 8 hours or more per day 
sitting,) and were healthy males or postmenopausal women with normal mobility 
between the ages of 20-49 who answer “no” to all of the questions on the Physical 
Activity Readiness Questionnaire (PARQ). Initially, the intent was to only include males 
between the ages of 40 and 69, as there is an increased risk for cardiovascular disease in 
that specific population
61
. However, after low response rate during the recruitment phase 
with the limited inclusion criteria, changes were made to the protocol. There is an age-
related increase in CVD incidence and mortality in both sexes, but to a greater extent in 
women
61
. As sedentary adult men and postmenopausal women are at risk for metabolic 
syndrome and cardiovascular disease, it was determined that this population was suitable 
for this study
56, 92
. The actual age range of subjects who completed the study was 32-66. 
Premenopausal women have higher levels of estrogen. It is hypothesized that the estrogen 
is protective against atherosclerosis and cardiovascular disease, so the premenopausal 
population was excluded from the study
90
. The changes to the inclusion criteria were 
approved by the Arizona State University IRB. Exclusion criteria were as follows: high 
blood pressure and/or gluten or nut allergies and/or the unwillingness to participate in a 
six week walking intervention or comply with testing protocols.  
 30 
 
 
Recruitment 
A total of 13 participants were recruited on a rolling basis between January-May of 2016. 
The goal was to recruit 50 participants. Participants were recruited through the Diocese of 
the Easy Valley, the Downtown YMCA, and Arizona State University. Efforts were 
made to recruit through the VA, Arizona Hellenic Educational Progressive Association 
(AHEPA), the Masonic Lodge and the Tempe Elks Lodge. Many of these locations did 
not allow flyers to be posted or did not have members that fit the eligibility criteria. 
Listservs were obtained through these organizations, and flyers were distributed. 
Interested participants were directed to complete an online survey and PARQ. Those who 
qualified and were still interested in participating were contacted and recruited for 
screening. At the first visit, participants provided written consent. The Institutional 
Review Board at Arizona State University approved this study prior to recruitment. 
Changes to the protocol were approved by the IRB.  
 
Study Design 
This study was conducted as an 8-week randomized parallel two-arm trial. Enrolled 
participants were stratified by age, BMI, and activity level and randomly assigned to 
either the almond group (ALM) or control group (CON). Subjects were randomized via a 
randomized number generator (Appendix F).  
Independent variables:  All participants were instructed to increase their daily step 
count gradually over the period of two weeks to reach 10,000 steps daily. Participants 
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received an Omron pedometer and instructions on how to use the pedometer. For one 
week prior to the start of the intervention, the subjects recorded their daily steps and the 
daily average was determined at Visit 2. The participants received instructions to limit 
nut consumption to only those provided to them during the study, with the allowance of 
two additional servings per week. The participants were randomized into two groups 
using a random number generator, and were entered into either the almond group (ALM) 
or the control group (CON). At the baseline visit (week 1 of the intervention), 
participants were encouraged to increase step counts by 1000-2000 steps weekly to reach 
10,000 steps within two weeks and to maintain this level of walking for the remainder of 
the 8-week trial. Participants randomized to the almond group were instructed to 
consume 2.5 oz almonds daily (~58 whole kernels or 413 kcal), which were distributed to 
them in 2.5 oz serving packages at Visit 3. Participants randomized to the control group 
were instructed to consume 4 tablespoons of an isocaloric cookie butter daily. A 
tablespoon measuring tool and 4 jars of cookie butter were distributed to these 
participants at Visit 3. Participants were instructed to consume their almonds or cookie 
butter as a daily snack. They were also instructed not to alter their typical diet patterns 
throughout the study (Appendix F).    
Dependent variables: Outcome measures were assessed at baseline and trial weeks 5 
and 8 and included anthropometrics, fitness test (step test), blood pressure, body 
composition, flow-mediated dilation, and fasting blood samples. On test days, 
participants arrived fasted for 12 hours (no food or drink except water) and refrained 
from strenuous exercise for the prior 48 hours and alcohol and caffeine for the prior 24 
hours. Use of antihistamines and vitamin C supplementation were restricted for the 5-day 
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period prior to testing. Emails were sent out to participants as reminders prior to each 
visit, which included instructions about restrictions. A blood sample was drawn at each 
visit. All blood draws were performed by a registered nurse, and flow mediated dilation 
was measured by a trained stenographer. Data from participants’ pedometers were 
downloaded upon each visit (Appendix F).  
Statistical analyses: All data are expressed as the mean ± SD. SPSS version 23 was 
used to perform statistical analyses. Baseline variables for subjects in each group were 
compared by t-tests and changes in variables between and within groups were assessed 
by one-way analysis of covariance. A p-value of ≤0.05 will be considered statistically 
significant. The Shapiro-Wilk test was used to check normality. 
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Chapter 4 
DATA & RESULTS 
 Recruitment for this randomized control trial took place from January to May 
2016. The total number of survey responses during this time period was 64. Out of the 64 
responses, 21 individuals were eligible for the study, and 15 respondents enrolled in the 
study. The 6 eligible participants who did not enroll did not respond to emails regarding 
scheduling an initial consent meeting. One participant dropped out during the initial week 
of the trial. A second participant was disqualified due to high blood pressure readings. 
Another participant dropped out at week 4 due to an ankle injury sustained during a hike. 
The remaining 12 participants at week 5 were stratified by age, height, weight, BMI, 
body fat percentage, and baseline step count, and randomized to the intervention (ALM) 
or control (CON) group. This resulted in 6 subjects in the ALM group and 6 subjects in 
the CON group and these subjects were included in the data analysis (Table 1). 
Participants reported 100% compliance on their calendars. 
Table 1.  Baseline characteristics of the two study groups:  almond (ALM) and control (CON) 
 ALM CON P valuea 
N (M/F) 2/4 1/5  
Age (y) 55.5±8.6 52.7±10.9 0.629 
Weight (kg) 77.2±11.7 72.6±8.7 0.482 
Height (cm) 166.2±10.6 168.5±7.3 0.667 
Body Fat (%) 33.1±8.3 34.3±9.4 0.817 
Fat Free Mass 51.8±11.6 47.7±8.0 0.486 
BMI (kg/m2) 28.0±4.0 25.6±1.8 0.204 
METS 33.2±20.8 71.7±52.8 0.128 
Data are the mean±SD.  
a
Independent t-test analysis.   
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The increase in steps from week 0 to week 5 was significant (p=0.025), with the 
average increase in steps being 2,043 steps. The change overall for the whole 8 weeks 
was not significant (p=0.090), with the change in steps from baseline to week 8 being 
1,672 steps (Table 2).  
Table 2.  Pre- and post-intervention step count data for participants consuming almonds 
daily (ALM) or a placebo daily (CON) 
 ALM n=6 CON n=6 P value
a
 [2p]
b 
Baseline 8278±1657 7848±2673  
Week 1 8298±1722 8917±2090  
Week 2 8575±1996 9193±1945  
Week 3 10217±2152 9055±1806  
Week 4 9639±2268 10295±1420  
Week 5 9729±2068 10482±1348  
Change (week 0 to week 5) ±1450±2378 ±2635±2981 0.025 [0.408] 
Week 6 9968±2005 10034±2244  
Week 7 9865±1165 10286±678  
Week 8 10404±1845 9066±2347  
Change (week 0 to week 8) ±2126±2418 ±1219±3628 0.090 
[0.261] 
Data are the mean±SD.  
a
Repeated Measures ANOVA for change over time.   
b
Effect size:  
partial eta-squared 2p.  The change in step counts at week 5 or week 8 did not differ 
between groups. 
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Figure 1. Changes in weekly step count among participants in both the ALM and CON groups. 
An independent t-test showed that the change in resting heart rate (RHR) from 
week 5 to week 8 was not significantly different between ALM and CON (p = 0.968). 
The change in peak heart rate (PHR) from week 5 to week 8 was not significantly 
different between ALM and CON (p=0.665). The change in heart rate recovery (HRR) 
from week 5 to week 8 was not significantly different between ALM and CON 
(p=0.818)(Table 3). The Shapiro-Wilk test was used to check normality. Data were 
normally distributed with the exception of Heart Rate Recovery at week 5. After a log 
transformation and square root transformation, the numbers stayed similar, so the original 
data was used in the analyses. 
 RHR did not begin to decrease until week 5 for both ALM and CON. The 
decrease from week 5 to week 8 was not significantly different between groups (p = 
0.968) (Table 3, Figure 4). For PHR, the ALM group decreased across the 8 weeks 
consistently, although the decrease was not significant. The PHR for CON increased until 
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week 5, and then began to decrease from week 5 to week 8(Table 3). These changes were 
not significant between groups (p=0.665). Similar trends occurred with HRR. HRR 
increased, though not significantly, from week 0 to week 5, then decreased from week 5 
to week 8 in both the ALM and CON groups, but there was no significant difference 
between groups (p=0.818) (Figure 3, Figure 4). Interestingly, during the walking 
intervention, PHR is the only heart rate measure that decreased, while HRR and RHR 
increased (Figure 3). After the dietary intervention, all three measures decreased, though 
not significantly (Figure 2, Figure 4).  
Table 3.  Pre- and post-intervention data and change data for participants consuming 
almonds daily (ALM) or a placebo daily (CON) 
 ALM n=6 CON n=6 P value
a
 [2p] 
Resting heart rate    
Baseline 73.8±6.7 72.5±11.1  
Week 5 77.0±7.1 72.7±5.7  
Change (baseline to week 5) +1.7±8.6  
Week 8 76.2±3.4 72.0±6.8  
Change (week 5 to week 8) -0.8±8.6 -0.7±4.5 0.968 [0.000] 
Heart rate recovery    
Baseline 99.7±11.0 81.0±21.8  
Week 5 97.8±3.5 85.5±15.5  
Change (baseline to week 5) +1.3±13.5  
Week 8 94.0±9.7 83.0±12.6  
Change (week 5 to week 8) -3.8±11.3 -2.5±8.0 0.818 [0.006] 
Peak heart rate    
Baseline 154.2±7.6 142.8±23.1  
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Week 5 150.0±8.2 145.8±17.9  
Change (baseline to week 5) -0.6±9.8  
Week 8 147.3±12.1 144.3±20.5  
Change (week 5 to week 8) -2.7±5.3 -1.5±3.6 0.665 [0.002] 
Data are the mean±SD.  
a
One-way analysis of covariance for change by group controlling 
for pre-intervention value.  
b
Partial eta-squared 2p.   
 
 
 
Figure 2. Changes in heart rate (rest, peak, and recovery) in beats per minute from week 5 to week 8 for 
ALM and CON.  
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Figure 3. Changes in heart rate (rest, peak, and recovery) in beats per minute from week 0 to week 5 for all 
participants.  
 
 
Figure 4. Changes in heart rate (rest, peak, and recovery) in beats per minute from week 5 to week 8 for all 
participants.  
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Figure 5. Changes in heart rate recovery in beats per minute for each individual participant over the course 
of the 8 weeks.  
 
Figure 6. Changes in resting heart rate in beats per minute for each individual participant over the course of 
the 8 weeks.  
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Figure 7. Changes in heart rate peak in beats per minute for each individual participant over the course of 
the 8 weeks.  
 Although neither weight loss nor body fat loss were part of the hypothesis, these 
data were examined. The change in weight was not significant (p=0.674). The mean 
weight of ALM increased from 77.1± kg to 77.6 kg over the course of the 8 weeks, while 
the mean weight of CON had a slight increase from 72.8 kg to 72.9 kg over the course of 
the 8 weeks. The change in body fat was significant (p=0.023), as shown by a slight 
increase in body fat percentage demonstrated by the overall group. The mean body fat of 
ALM increased from 33.1% to 34.4% over the course of the 8 weeks, though this change 
was not significant. The mean body fat of CON decreased from 34.3% to 33.5% over the 
course of the 8 weeks, though this change was not significant (Table 4). 
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Table 4.  Pre- and post-intervention weight and body fat data for participants 
consuming almonds daily (ALM) or a placebo daily (CON) 
 ALM n=6 CON n=6  
Weight (kg)    
Baseline 77.2±11.7 72.8±8.7  
Week 5 76.9±11.5 73.0±8.4  
Week 8 77.6±11.2 72.9±8.7  
Body fat (%)    
Baseline 33.1±8.3 34.3±9.4  
Week 5 34.1±8.3 33.5±8.9  
Week 8 34.5±8.5 33.5±8.3  
Data are the mean±SD.   
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Table 5.  Pre- and post-intervention YMCA step test rating data for participants consuming 
almonds daily (ALM) or a placebo daily (CON) 
 
Participant No. Baseline Week 5 Week 8
 
Group 
1 Above Average Above Average Above Average ALM 
2 Excellent Excellent Excellent CON 
3 Above Average Good Excellent CON 
4 Good Average Good ALM 
6 Above Average Excellent Good ALM 
7 Good Good Excellent ALM 
9 Excellent Excellent Excellent CON 
10 Excellent Excellent Excellent CON 
12 Above Average Good Good ALM 
13 Above Average Good Good ALM 
14 Above Average Good Good CON 
15 Excellent Excellent Excellent CON 
Ratings from guidelines published by the YMCA.   
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Chapter 5 
DISCUSSION 
In this 8-week randomized parallel two-arm trial, 8 weeks of increasing the daily 
step count to a goal of 10,000 steps per day and 3 weeks of consumption of 2.5 oz of 
almonds did not significantly change heart rate recovery or resting heart rate as compared 
to a placebo (4 tbsp of cookie butter per day). Participants did increase their step counts 
over the course of the 8 weeks, as confirmed by the data collected from their pedometers.  
Although the changes in heart rate recovery were not statistically significant, 6 of 
the 12 participants did move up a ranking on the age-adjusted standards based on 
guidelines published by the YMCA (Appendix A, Table 5).  Notably, all of the 
participants started out with a heart rate recovery rating between “above average” and 
“excellent.” In future studies, researchers may want to include a certain heart rate 
recovery rating in their inclusion criteria. The almond group achieved a change of 3-5 
bmp in their HRR, which is meaningful, and can move someone up on the ranking by 
YMCA standards. Four participants in the ALM group and two participants in the CON 
group moved up a category in the YMCA ranking system (i.e. “good” to “excellent” or 
“above average” to “good”) from week 0 to week 8. Three participants in the ALM group 
moved up a ranking in the walking intervention from week 0 to week 5, and two moved 
up a ranking in the dietary intervention from week 5 to week 8. In the control group, one 
participant moved up a ranking during the walking intervention from week 0 to week 5, 
while another dropped down a ranking. The participant who dropped down a ranking 
moved back up to their baseline ranking after the dietary intervention. One participant in 
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the CON group moved up a ranking in the dietary intervention from week 5 to week 8 
(Table 5).  
In the United States, the average BMI is 26.6 for an adult male and 26.5 for an 
adult woman
49
. In this study, the ALM group had a mean BMI of 28.0 at baseline and 
CON group had a mean BMI of 25.6 at baseline. Based on BMI, the participants did 
represent the typical American population.  
A review of the literature suggests that the daily step count for Americans is 
highly variable, with healthy adults taking anywhere between approximately 4,000 and 
18,000 steps per day. Studies included in the review typically considered ≤5,000 steps per 
day to be sedentary
100
. The ALM group in this study started with a baseline mean step 
count of 8,278 steps, and the CON group started with a baseline mean step count of 7,848 
steps per day. The population in this study is not representative of the average American 
when it comes to step count. Walking 10,000 steps a day would be nearly double the 
average step count for sedentary Americans, but for our participants, 10,000 steps was 
just 2,000-3,000 more steps than they started with. Many of our participants were college 
employees. Their baseline step count is consistent with another pedometer-based study 
which used college employees as participants
22
. It is possible that college employees do 
not sit as much throughout the day in comparison to the average American. In future 
studies, it may be beneficial to use more stringent guidelines to define participants as 
“sedentary”. Based on the step test guidelines by the YMCA, all of our participants were 
ranked “above average” to “excellent” at baseline, meaning that they were seen as 
moderately fit to fit based on heart rate recovery
108
.  
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Past trials investigating the effect of dietary and weight loss interventions on heart 
rate recovery saw significant change after interventions lasting 12-16 weeks
10, 18, 101
. It 
may be the case that longer interventions are necessary to see significant change in HRR. 
Our physical intervention lasted 8 weeks, and our dietary intervention lasted just 3 weeks.  
In future studies, a different placebo may be recommended to ensure that no 
ingredients from the cookie butter were affecting results (such as coconut oil). Many 
studies in the literature assign the control group to a “habitual diet” void of nuts rather 
than using a placebo
19, 103
 Another study used a muffin in the control phase of the trial
59
. 
The daily serving of 2.5 oz of almonds is sufficient for future studies, as it represents a 
realistic serving to recommend to the general public as an intervention. Despite 
consuming an additional 400 calories per day, no significant weight was gained as a 
result of the diet change. This may be a result of the increase in physical activity, or 
compensating by eating less throughout the day. Future studies should exclude 
participants who have “good” or “excellent” heart rate recovery ratings at baseline. 
Future studies should also either exclude participants with a higher step count at baseline 
or have the participants walk a certain number of steps above their baseline step count 
rather than aiming for 10,000. The participants in this study were more active than the 
typical person. As most of the participants were fairly fit at baseline according to the 
YMCA guidelines, the VO2 max test could have been used in this study. The YMCA 3-
minute step test was used in order to reduce the burden on participants.  
Although the participants reported 100% compliance to both almond consumption 
and walking 10,000 steps per day, it is quite plausible that the additional steps they were 
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taking were not at a “moderate” or “vigorous” pace. In future studies, it would be optimal 
to have participants perform their exercise under the supervision of the investigators, so 
that intensity and heart rate can consistently be monitored during the exercise. In addition 
to monitoring the exercise, participants could also consume the almonds during their visit 
to ensure compliance. An average walking pace is about a mile in 15 minutes. A mile is 
typically between 1,760 and 2,640 steps
99
. Based on this information, the participants in 
this study were only adding about one mile, or 15 minutes of exercise into their routine. If 
the subject pool was more representative of the American population, increasing their 
step count to 10,000 steps per day would be closer to an additional 4 miles, or roughly 
one hour of exercise into their routine per day. This would be more in line with the 
Physical Activity Guideline. These additional steps were taken on a daily basis, 
participants in this trial were likely averaging about 105 additional minutes of exercise 
above their baseline activity level. If this was vigorous activity, they would meet the 
physical activity guidelines of at least 60 minutes per week of vigorous intensity exercise. 
However, if this was moderate-intensity exercise, as the participants were directed to 
perform, 105 minutes falls short of the guidelines for moderate-intensity exercise
48
. The 
guidelines do not include suggestions for low-intensity exercise. Although one would 
need to perform low-intensity activity for longer periods of time to be comparable to the 
guidelines for moderate and vigorous activity, this does not mean that low-intensity 
exercise should be excluded from the guidelines. This is something to consider in future 
revisions to the physical activity guidelines.  
Strengths. Participants were screened for a number of exclusion criteria. These included 
having chronic diseases, gluten and other food allergies, physical ailments, smoking, 
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physical ailments that would interfere with the ability to participate in a walking program, 
high activity level and high blood pressure. Inclusion criteria included willingness to 
travel to campus on four occasions, willingness to consume nut products daily, answering 
“no” to all questions on the PARQ, and sitting more than 8 hours per day. Since 
pedometer data was downloaded through the Omron program to a PC, adherence to the 
walking program was monitored. Additionally, participants were randomized, which 
prevented participants from knowing what treatment they were receiving. 
Limitations. This trial had several limitations. The intended target population was 
sedentary individuals. Based on the sedentary guidelines, the subjects were considered 
unfit. However, based on the step test data, the participants in this study were already 
above average fitness level at baseline. The average step count at baseline was 8,609 
steps per day for all participants. It is quite possible that although we instructed 
participants to walk at a moderate pace, their additional steps may have been more of a 
“stroll” or low-intensity activity. Perhaps the level of intensity was not high enough to 
see a change in physical fitness. This should be a consideration in future studies. The 8-
week intervention was short in comparison to trials that included a dietary or weight loss 
intervention of 12-16 weeks
10, 18, 101
. Subtle changes in heart rate measures were not seen 
until week 5, which suggests that it may take longer to see significant changes in heart 
rate recovery and resting heart rate. Despite the goal to enroll 50 participants in the trial, 
only 12 completed the study. The initial goal was to enroll 50 males between the ages of 
40-69 in the study, but due to lack of responses to enrollment surveys, the IRB protocol 
was changed to allow men between the ages of 20-69, and postmenopausal women to 
enroll in the study.  
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Conclusion. This randomized control trial suggests that the daily consumption of 2.5 oz 
of almonds for 3 weeks in conjunction with an 8 week walking program does not lead to 
changes in heart rate recovery or resting heart rate.  Future trials on this topic would 
benefit from having strict guidelines on the definition of “sedentary”, a larger sample 
size, a longer trial, having participants perform exercise and consume almonds under 
supervision, and using the VO2   max test rather than the YMCA step test. 
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